Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,088 across all filing types
Latest filing 2025-01-08 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
关于聘任高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement from a company about changes in senior management positions, including appointments and title adjustments of executives such as general manager, senior vice general managers, and vice general managers. It includes detailed biographies and qualifications of the appointed individuals. There is no financial data, earnings information, or regulatory filings related to financial performance. The content clearly pertains to management changes and appointments. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 2760 characters, which is consistent with a typical management announcement rather than a full report or regulatory filing.
2025-01-08 Chinese
第四届监事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution of the fourth meeting of the fourth Supervisory Board of Xiamen Aide Biomedical Technology Co., Ltd. It details the meeting attendance, voting results, and election of a new chairman of the Supervisory Board. There is no financial data, no mention of annual or quarterly reports, no audit information, and no regulatory certifications. The content focuses on board/management changes, specifically the election of a new Supervisory Board chairman. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Hence, the classification is MANG with high confidence.
2025-01-08 Chinese
第四届董事会第四次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of resolutions passed at the fourth meeting of the fourth board of directors of Xiamen Aide Bio-Pharmaceutical Technology Co., Ltd. It details changes in management positions such as the adjustment of the general manager's title and the appointment of senior vice general managers and vice general managers. The document includes voting results and references to related announcements filed on the stock exchange disclosure website. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes in the company's board and senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a full report or announcement of a report publication.
2025-01-08 Chinese
关于变更监事会主席暨职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement from a company about changes in its supervisory board, specifically the resignation of the chairman of the supervisory board and the election of a new chairman. It details the resignation, the reasons, the election process, and the qualifications of the new chairman. There is no financial data, no mention of annual or quarterly reports, no audit information, no earnings data, and no other types of filings such as mergers or dividends. The content clearly relates to changes in the company's board or senior management structure. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, confirming this classification with high confidence.
2025-01-08 Chinese
关于回购股份进展的公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement from a company regarding the progress of its share repurchase program. It details the number of shares repurchased, the price range, total amount spent, compliance with regulatory guidelines, and future plans for the buyback. There are no financial statements or detailed financial analysis present, and the document is relatively short (1146 characters). This matches the description of a Transaction in Own Shares (POS) filing, which reports on the company's buyback activities. It is not an announcement of a report publication, nor a full financial report, nor a regulatory certification. Therefore, the correct classification is POS with high confidence.
2025-01-03 Chinese
关于部分限制性股票回购注销完成的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the completion of a repurchase and cancellation of restricted shares under a 2023 restricted stock incentive plan. It details the number of shares repurchased, the price, the approval process, and the impact on share capital. There is no financial statement or detailed financial report included, only a disclosure of a share repurchase transaction related to restricted stock. This fits the category of a Transaction in Own Shares (POS), which covers company buybacks or cancellations of its own shares.
2024-12-17 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.